Dynorphin A
Latest Information Update: 30 Jan 2001
Price :
$50 *
At a glance
- Originator Neurobiological Technologies
- Class Opioid analgesics
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer pain; Postoperative pain